Back

Drug-use-associated infective endocarditis in Denmark

1 September 2024 (10:00 - 10:50)
Organised by: Logo
Congress Presentation Part of: New findings in infective endocarditis Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jeppe Kofoed Petersen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

7 More presentations in this session

Presentation thumbnail
Postoperative heart valve infection, when and which bacteria: a nationwide cohort study
Mrs C. Holgersson (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Increased risk of infective endocarditis following transurethral resection of the prostate (TUR-P)
Ms A. Stahl (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
First in-human study of 64Cu-DOTATATE positron emission tomography/computed tomography(PET/CT) in infective endocarditis: a prospective head-to-head comparison with 18-FDG PET/CT
Doctor K. Hadji-Turdeghal (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Preliminary results from the Polish Infective Endocarditis Registry (POL-ENDO): time to change clinical approach?
Doctor J. Orzech (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Role of negative transthoracic echocardiography in excluding infective endocarditis
Doctor N. Cambise (Rome, IT)
Abstract Slides Video

Access the full session

Session thumbnail
New findings in infective endocarditis

The Event

Event poster

ESC Congress 2024

1 September 2024 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Definite versus possible infective endocarditis: a nationwide cohort study from the NIDUS database
29 August 2025
thumbnail
Congress Presentation
Clinical, genetic, and prognostic implications of illicit drug use in dilated cardiomyopathy
9 May 2026
thumbnail
Congress Presentation
Infective endocarditis and intravenous drug use: challenges in diagnosis and treatment.
26 August 2022
thumbnail
Congress Presentation
Implementation of prasugrel and prognostic outcomes after percutaneous coronary intervention for myocardial infarction: a nationwide observational study
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources